Erin Everett
Primary Care · Atlanta, GANPI 1891154613
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 345 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by Viiv Healthcare Company at 30.8% of the total. Among primary care clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 345 payments — averaging $19.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$2K
- Gilead$2K
- Merck$507
- Lilly USA, LLC$487
- AbbVie$329
- Theratechnologies Inc.$229
- plus $2K from 22 others
What the payments were for
- Food & beverage$6,60898%
- Education$1642%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 116 | $2,084 |
| Gilead | 66 | $1,571 |
| Merck | 24 | $507 |
| Lilly USA, LLC | 28 | $487 |
| AbbVie | 20 | $329 |
| Theratechnologies Inc. | 11 | $229 |
| Johnson & Johnson | 16 | $224 |
| EMD Serono, Inc. | 9 | $194 |
| Novo Nordisk | 10 | $188 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $176 |
| Antares Pharma, Inc. | 6 | $107 |
| Janssen Products, LP | 1 | $99 |
| Verity Pharmaceuticals Inc. | 5 | $83 |
| Janssen Scientific Affairs, LLC | 1 | $68 |
| Acerus Pharmaceuticals Corporation | 3 | $66 |
| Pfizer | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $44 |
| Tolmar, Inc. | 2 | $38 |
| Clarus Therapeutics Inc. | 2 | $36 |
| Halozyme Inc | 2 | $34 |
| Dexcom, Inc. | 2 | $32 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Exact Sciences | 1 | $24 |
| Abbott | 1 | $22 |
| GSK | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,772 in reported general payments places this provider in the 95th percentile of 235 primary care providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 24 | $92,254 |
| OzempicSemaglutide | 18 | $47,809 |
| TrulicityDulaglutide | 11 | $20,355 |
| JatenzoTestosterone Undecanoate | 13 | $12,727 |
| JanuviaSitagliptin Phosphate | 13 | $10,458 |
| Testosterone | 11 | $707 |
| Atorvastatin Calcium | 57 | $473 |
| ValacyclovirValacyclovir Hcl | 12 | $358 |
| Ondansetron OdtOndansetron | 11 | $246 |
| Mirtazapine | 19 | $243 |
| Levothyroxine Sodium | 15 | $241 |
| Metformin Hcl ErMetformin Hcl | 22 | $209 |
| Tramadol Hcl | 11 | $206 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 11 | $194 |
| Amlodipine Besylate | 36 | $151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $1,571 | $92,25424 claims |
| Novo NordiskOzempic | $188 | $47,80918 claims |
| Lilly USA, LLCTrulicity | $487 | $20,35511 claims |
| Clarus Therapeutics Inc.Jatenzo | $36 | $12,72713 claims |
| MerckJanuvia | $507 | $10,45813 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 235 primary care providers in Georgia.
Other primary care in Atlanta
- Erin BartonAtlanta$6K
- Natasha WilliamsonAtlanta$5K
- Lauren BolleAtlanta$4K
- Karen GuidryAtlanta$3K
- Caroline ClaarAtlanta$3K
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.